 This randomized phase III multicenter trial aims to assess the impact of virtual reality helmets visual and audio during VCB in patients treated for endometrial cancer, in terms of pain primary endpoint, and in terms of anxiety secondary endpoint. Randomization will define which patient will wear a virtual reality helmet. Stratification will be performed according to the following criteria: vaginal molded applicator versus cylinder, two applications versus four; 70 years versus 70 years. 